An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy
Clinical trial NCT06270719 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06270719
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-07
- Primary completion
- 2029-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.